Online Patient Advocate Meeting on September 7th 2020 Carin A. Uyl-de Groot studied Health Care Policy and Management at the Erasmus University Rotterdam. From March 1990 onwards she is working at the institute for Medical Technology Assessment/Department of Health Care Policy and Management at the Erasmus Medical Centre Rotterdam where she is currently professor. Her…Continue reading Fair drug pricing
When initiating the action plan for Latin America, it is of vital importance to identify the challenges that the region faces in terms of oncology. Latin America is made up of 20 countries and has a total of 650 million inhabitants, all have different health policies, economies, and budgets dedicated to health. Health in Latin…Continue reading Hub update: Latin America
Sometimes people see Inspire2Live as the driving force behind criticism on the pharmaceutical industry when it comes to the prices of especially newly developed treatments for cancer patients. Although sometimes that happens to be the case, it most certainly isn’t our main focus. As patients we even don’t care very much about pricing. Like our…Continue reading Pharmaceutical industry, friend or foe?
Concentratie van kankerzorg.. Inspire2Live streeft hier al jaren naar. Zo kun je de kwaliteit verbeteren én patiënten helpen met informatie over ziekenhuiskeuze. De website www.inspire2go.nl informeert en ondersteunt patiënten bij de keuze voor het beste ziekenhuis. Naar verschillen tussen de behandelingen en de resultaten in verschillende centra is ook veel onderzoek gedaan. Dit artikel op…Continue reading Concentratie van kankerzorg
Every two weeks an update is published of the Hub initiative. Hubs are created in Brazil, Uruguay, Costa Rica, New England (USA), Armenia, Egypt, Kenia, Nigeria and Ghana (Africa), Singapore, Australia and elsewhere. Africa “What does the cancer world learn from non-Western countries?” and “What does Inspire2Live do for non-Western countries”? These were questions raised…Continue reading Hub update: Africa
On our Inspire2Live Annual Congress, Olufunmilayo Olopade (she also responds to Funmi) picks up the tenet of the keynote lecture ‘We need to focus on prevention’ by Bob Weinberg She grew up in Nigeria, where resources are low, and she learned medicine based on the message: ‘prevention is better cure’. That’s the area of her research,…Continue reading Keynote lecture: Breast Cancer Risk Assessment and individual treatments
On June 5th 2020, Inspire2Live organised a tele-consultation session. Objective was to consult four leading scientists about our global future. Inspire2Live is committed to expanding its presence among patients and researchers all over the world. We will challenge scientists that support us to become scholar activists. Three weeks later, on June 26th the four science…Continue reading The Global Future of Inspire2Live
I have cancer for 15 years now and I’m still living a happy and healthy life in harmony with it. The fact I am still alive is the result of a significant number of timely interventions during those 15 years. The present Corona crisis has had a very dangerous side effect for us cancer patients….Continue reading What if you suffer from cancer?
Through the Discovery Network in Belfast at the end of 2017 pancreatic cancer was identified as one of the two deadliest forms of cancer with little progress in the treatment for decades and with poor prospects. Themes where Inspire2live is involved can be roughly divided into four topics. Targeted, personalized therapy DNA-RNA sequencing based identification…Continue reading Inspire2Live & Pancreatic Cancer
It’s good to see that there are so many initiatives concerning personalized medicine, and not just in relation to cancer patients. First there is the initiative of a majority in Dutch Parliament calling on the Minister of Health to make Whole Genome Sequencing (WGS) available for every cancer patient with metastasized solid cancer before a…Continue reading Open Source Pharma NL